<DOC>
	<DOC>NCT00452491</DOC>
	<brief_summary>1. To test for equivalence in terms of catch-up growth between the 2 therapeutic regimens 2. To specify the best period of treatment 3. To assess the efficacy of treatment based on final adult height of these children</brief_summary>
	<brief_title>MAXOMAT Â® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal Children</brief_title>
	<detailed_description />
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>Prepubertal children of either sex presenting with severe early onset intrauterine growth retardation (I.U.G.R.) Height Less Than or Equal to 3 SD Age less than 3 years The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>